Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis

被引:5
|
作者
Oh, Ju Hyun [1 ]
Kang, Jieun [2 ]
Song, Jin Woo [3 ]
机构
[1] Inje Univ, Sanggye Paik Hosp, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea
[2] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, Goyang Si, Gyeonggi Do, South Korea
[3] Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
hypersensitivity pneumonitis; mortality; prognosis; fibrosis; high-resolution computed tomography; IDIOPATHIC PULMONARY-FIBROSIS; FLEISCHNER-SOCIETY; CT FINDINGS; SURVIVAL; LUNG; STANDARDIZATION; PROGNOSIS; INDEXES;
D O I
10.3389/fmed.2023.1131070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundVariable clinical courses make it challenging to predict mortality resulting from fibrotic hypersensitivity pneumonitis (HP). This study evaluated the usefulness of radiologic parameters for predicting mortality in patients with fibrotic HP. MethodsClinical data and high-resolution computed tomography (HRCT) images, which were scored for reticulation, honeycombing, ground glass opacity (GGO), consolidation, and mosaic attenuation (MA) by visual assessment, were retrospectively analyzed in a total of 101 patients with fibrotic HP (all biopsy-proven cases). Fibrosis score was defined as the sum of reticulation and honeycombing scores. ResultsThe mean age of the 101 patients was 58.9 years, and 60.4% were females. During the follow-up (median: 55.5 months; interquartile range: 37.7-89.0 months), the 1-, 3-and 5-year mortality rates were 3.9, 16.8, and 32.7%, respectively. The non-survivors were older and had significantly lower lung function and minimum oxygen saturation during the 6-min walk test than the survivors. The non-survivors had higher scores of reticulation, honeycombing, GGO, fibrosis, and MA on HRCT than survivors. In the multivariable Cox analysis, reticulation, GGO, and fibrosis scores were independent prognostic factors for mortality in patients with fibrotic HP, as well as age. Fibrosis score showed great performance for predicting the 5-year mortality (AUC = 0.752, p < 0.001) and higher mortality was recorded for patients with high fibrosis score (>= 12.0%) (the mean survival time: 58.3 vs. 146.7 months, p < 0.01) than those without. ConclusionOur results suggest that radiologic fibrosis score may be a useful predictor of mortality in patients with fibrotic HP.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis
    D'Alessandro, Miriana
    Bergantini, Laura
    Cameli, Paolo
    Landi, Claudia
    Lanzarone, Nicola
    Perrone, Anna
    Alonzi, Valerio
    Perillo, Felice
    Bianchi, Francesco
    Refini, Rosa M. E. T. E. L. L. A.
    Pieroni, Maria
    Sestini, Piersante
    Bargagli, Elena
    [J]. PANMINERVA MEDICA, 2022, 64 (04) : 548 - 554
  • [22] Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?
    Pereira, Joao O.
    Fernandes, Vania
    Alfaro, Tiago M.
    Freitas, Sara
    Cordeiro, Carlos Robalo
    [J]. LIFE-BASEL, 2023, 13 (02):
  • [23] Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort
    Almeida, Leonor Mendonca
    Fernandes, Ana Luisa
    Cardoso, Catarina Gouveia
    Lima, Bruno
    Neves, Ines
    Novais-Bastos, Helder
    Mota, Patricia Caetano
    Melo, Natalia
    Moura, Conceicao Souto
    Guimaraes, Susana
    Carvalho, Andre
    Cunha, Rui
    Pereira, Jose Miguel
    Morais, Antonio
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [24] Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort
    Almeida, Leonor Mendonca
    Fernandes, Ana Luisa
    Cardoso, Catarina Gouveia
    Lima, Bruno
    Neves, Ines
    Novais-Bastos, Helder
    Mota, Patricia Caetano
    Melo, Natalia
    Moura, Conceicao Souto
    Guimaraes, Susana
    Carvalho, Andre
    Cunha, Rui
    Pereira, Jose Miguel
    Morais, Antonio
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [25] Hypersensitivity Pneumonitis: Corticosteroid Effect in Pneumonitis with Fibrosis
    Manych, Matthias
    [J]. PNEUMOLOGIE, 2020, 74 (05): : 252 - 252
  • [26] The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis
    Vourlekis, JS
    Schwarz, MI
    Cherniack, RM
    Curran-Everett, D
    Cool, CD
    Tuder, RM
    King, TE
    Brown, KK
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 116 (10): : 662 - 668
  • [27] Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis
    Ejima, Masaru
    Okamoto, Tsukasa
    Suzuki, Takafumi
    Anzai, Tatsuhiko
    Takahashi, Kunihiko
    Miyazaki, Yasunari
    [J]. BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [28] Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis
    Masaru Ejima
    Tsukasa Okamoto
    Takafumi Suzuki
    Tatsuhiko Anzai
    Kunihiko Takahashi
    Yasunari Miyazaki
    [J]. BMC Pulmonary Medicine, 21
  • [29] Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
    Chen, Xueying
    Yang, Xiaoyan
    Ren, Yanhong
    Xie, Bingbing
    Xie, Sheng
    Zhao, Ling
    Wang, Shiyao
    Geng, Jing
    Jiang, Dingyuan
    Luo, Sa
    He, Jiarui
    Shu, Shi
    Hu, Yinan
    Zhu, Lili
    Li, Zhen
    Zhang, Xinran
    Liu, Min
    Dai, Huaping
    [J]. CHINESE MEDICAL JOURNAL, 2023, 136 (23) : 2839 - 2846
  • [30] Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
    Chen Xueying
    Yang Xiaoyan
    Ren Yanhong
    Xie Bingbing
    Xie Sheng
    Zhao Ling
    Wang Shiyao
    Geng Jing
    Jiang Dingyuan
    Luo Sa
    He Jiarui
    Shu Shi
    Hu Yinan
    Zhu Lili
    Li Zhen
    Zhang Xinran
    Liu Min
    Dai Huaping
    [J]. 中华医学杂志(英文版), 2023, 136 (23)